RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.72B
AUM Growth
-$153M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$141M
2
+$72.2M
3
+$26M
4
MRNA icon
Moderna
MRNA
+$24.9M
5
ZGNX
Zogenix, Inc.
ZGNX
+$20.6M

Top Sells

1
+$110M
2
+$49.6M
3
+$19.4M
4
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$19M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$16M

Sector Composition

1 Healthcare 95.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
– –
-900,000
27
– –
-2,535
28
– –
-350,933
29
– –
-3,030,303
30
– –
-6,196,143
1
2